Brown Michael S's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Sep 15, 2021
- Accession no.
- 0001708138-21-000082
- Filed
- Sep 15, 2021
- Trade date
- Sep 13, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 20 non-derivative transactions and 3 derivative transactions. Open-market sales total $6.29M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brown Michael SCIK 0001174475 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Common Stock | MOption exerciseAcquired | +2,479 | $380.95 | +$944,375.05 | 3,370 | Direct | |
| Sep 13, 2021 | Common Stock | MOption exerciseAcquired | +3,613 | $413.33 | +$1,493,361.29 | 6,983 | Direct | |
| Sep 13, 2021 | Common Stock | MOption exerciseAcquired | +3,612 | $413.33 | +$1,492,947.96 | 10,595 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $636.74 | −$63,674 | 10,495 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −200 | $637.29F2 | −$127,458 | 10,295 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −676 | $638.64F3 | −$431,720.64 | 9,619 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −203 | $639.20F4 | −$129,757.6 | 9,416 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $640.77 | −$64,077 | 9,316 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $641.12 | −$64,112 | 9,216 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −400 | $642.62F5 | −$257,048 | 8,816 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $643.49 | −$64,349 | 8,716 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $644.89 | −$64,489 | 8,616 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $645.66 | −$64,566 | 8,516 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −100 | $646.28 | −$64,628 | 8,416 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −151 | $647.58F6 | −$97,784.58 | 8,265 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −962 | $648.48F7 | −$623,837.76 | 7,303 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −838 | $649.46F8 | −$544,247.48 | 6,465 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −1,800 | $650.40F9 | −$1,170,720 | 4,665 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −3,712 | $651.10F10 | −$2,416,883.2 | 953 | Direct | |
| Sep 13, 2021 | Common Stock | SSaleDisposed | −62 | $652.26 | −$40,440.12 | 891 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2021 | Common Stock | MOption exerciseDisposed | −2,479 | $0.00 | $0 | 0 | Direct | |
| Sep 13, 2021 | Common Stock | MOption exerciseDisposed | −3,613 | $0.00 | $0 | 3,612 | Direct | |
| Sep 13, 2021 | Common Stock | MOption exerciseDisposed | −3,612 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents volume-weighted average price of sales of 200 shares of Company stock on September 13, 2021 at prices ranging from $637.20 to $637.37. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents volume-weighted average price of sales of 676 shares of Company stock on September 13, 2021 at prices ranging from $638.16 to $638.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents volume-weighted average price of sales of 203 shares of Company stock on September 13, 2021 at prices ranging from $639.09 to $639.32. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents volume-weighted average price of sales of 400 shares of Company stock on September 13, 2021 at prices ranging from $642.36 to $642.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F6
Represents volume-weighted average price of sales of 151 shares of Company stock on September 13, 2021 at prices ranging from $647.42 to $647.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F7
Represents volume-weighted average price of sales of 962 shares of Company stock on September 13, 2021 at prices ranging from $648.30 to $648.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F8
Represents volume-weighted average price of sales of 838 shares of Company stock on September 13, 2021 at prices ranging from $649.00 to $649.57. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F9
Represents volume-weighted average price of sales of 1,800 shares of Company stock on September 13, 2021 at prices ranging from $650.19 to $650.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.
- F10
Represents volume-weighted average price of sales of 3,712 shares of Company stock on September 13, 2021 at prices ranging from $651.10 to $651.21. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on September 13, 2021 at each separate price.
Referenced by the price of 1 transaction in Table I.